CAV1 and hypertensive disorder: To assess if there were also differences in the subcellular distribution and expression of caveolin-1 in neutrophils from patients with HTN and NTI, we performed double immunostaining using antibodies raised against α-ENaC and caveolin-1 labeled with Alexa-fluor 488 and Alexa-fluor 594, respectively.